GlassScriptPrepare for your visit
Christopher B Davis
Family · Salisbury, MD · NPI 1265483283
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$1,908.28
in general payments reported to CMS, 2019-2025 · $956 in 2025
The $956 reported for 2025 was more than what 86% of Family providers received nationally (typical 2025 total: $167).
Who reported paying
General payments only, top 6 by amount.
- Viiv Healthcare Company $253.52
- Gilead Sciences, INC. $233.25
- Abbvie INC. $157.00
- Novo Nordisk INC $119.74
- Merck Sharp & Dohme LLC $119.01
- Lilly USA, LLC $112.70
Drugs and devices associated with these payments
Dovato Mavyret Pifeltro Cologuard Collection Kit Delstrigo Veozah Mounjaro Omnipod Rybelsus Ozempic Rukobia Nurtec Odt
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Christopher Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/10534776/christopher-b-davis